Myriam Diaz martin

Led a commercial organization across Spain and international markets as a Steering Committee member, managing 26 sales reps, 6 sales directors, 2 KAMs, and 3+ support FTEs. Grew sales +19.4% vs. the prior year and negotiated distribution contracts in 13+ countries, including China.

Owned the Portugal P&L with 42 FTEs and €30M revenue, driving growth through government agreements to open 50 new dental clinics in hospitals and local medical centers. Led digital strategy and conversion/leads generation, launching Dentigram.com and delivering +30% growth in Portugal (2023 vs. prior year) and +11.3% ecommerce sell-out growth (2023 vs. 2022).

Managed Iberia commercial operations with 90 field sales consultants, 64 call center reps, and 10 product specialists, shifting execution from transactional to consultative sales. Drove account growth and launches including Reveal’s Clear Aligners and Edge Endo, increasing DSO business from €3M (2014) to €12M (2021) and contributing to Henry Schein revenue growth from €30M (2014) to €110M (2023).

Led worldwide B2B commercialization of active pharmaceutical ingredients, generic products, and OTC dossiers while managing a team of 12 area and country managers across Argentina, Chile, Brazil, China, India, Dubai, and Russia. Negotiated with top generic laboratories in 30+ countries and supported international footprint openings, including launching the first generic Capecitabine in Japan.

Designed and executed the sales strategy through the merger period with AstraTech in June 2011, leading 15 sales reps across Spain for Xive and Ankylos implants. Negotiated with KOLs and dental medical societies and implemented a sales force effectiveness program.

Founded and scaled “SKILLS,” a new business unit with 42 sales reps and 23 trade marketing consultants to develop an outsourced pharma/OTC sales force. Led the launch strategy for Boots SERUM 7 in Spain, signed major distribution contracts, and improved performance from EBITDA -432K€ (2007) to sales +165% and EBITDA +30K€ (2008) with no additional investment.

Owned P&L for a pharma retail business unit with 30 sales reps and 5 marketing FTEs, implementing a Direct To Pharmacy model across 2,000 pharmacies to increase brand loyalty versus generics. Achieved 2,200 direct pharmacies and €350M income in 2006 through cross-functional collaboration and key stakeholder negotiation.

Led a team of 10 sales representatives in South-Central Spain and drove OTC growth through sales mergers and brand promotion across major consumer categories. Negotiated with pharma wholesalers, purchase groups, and top FMCG retailers, increasing business volume by 38% in the area of responsibility.

Coordinated events, courses, and congresses while negotiating with trauma and maxillofacial chiefs of service. Supported a successful launch of the Proximal femoral nail to strengthen clinical adoption.

Degree in Economics from Universidad Autónoma de Madrid (UAM).

Completed a Senior Management Program at IE.

Completed a Master Degree in Internet Business at ISDI.

Agile Scrum certification (institution not specified).

Completed a Financial Management Program at CEF.

Completed a Master program in Business at IE.